Stock HESTERBIO HESTER BIOSCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hester Biosciences Limited

Equities

HESTERBIO

INE782E01017

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:50 2024-05-03 EDT 		5-day change 1st Jan Change
1,693 INR -0.29% Intraday chart for Hester Biosciences Limited +2.46% +16.05%
02-29 Hester Biosciences Names COO MT
02-29 Hester Biosciences Limited Announces Executive Changes CI

Valuation

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Capitalization 1 13,644 13,146 7,869 16,306 23,099 12,934
Enterprise Value (EV) 1 14,201 13,627 8,900 17,190 25,128 15,528
P/E ratio 53.3 x 31.6 x 27 x 47.4 x 58.7 x 48.6 x
Yield 0.62% 0.71% 0.71% 0.52% 0.37% 0.53%
Capitalization / Revenue 9.94 x 7.14 x 4.19 x 7.49 x 9.37 x 4.65 x
EV / Revenue 10.3 x 7.4 x 4.74 x 7.9 x 10.2 x 5.58 x
EV / EBITDA 28.7 x 18.4 x 14.7 x 23.9 x 35.2 x 24.9 x
EV / FCF -965 x 340 x -18.6 x 1,007 x -32.9 x -30.6 x
FCF Yield -0.1% 0.29% -5.38% 0.1% -3.04% -3.27%
Price to Book 9.7 x 7.41 x 3.91 x 7.14 x 8.88 x 4.62 x
Nbr of stocks (in thousands) 8,507 8,507 8,507 8,507 8,507 8,507
Reference price 2 1,604 1,545 925.0 1,917 2,715 1,520
Announcement Date 18-07-16 19-07-05 20-08-04 21-07-23 22-07-29 23-08-23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 1,373 1,842 1,878 2,177 2,466 2,782
EBITDA 1 494.5 742.6 604 720.3 712.9 624.2
EBIT 1 398.8 625.6 472.3 591.2 550.4 420.3
Operating Margin 29.04% 33.97% 25.15% 27.16% 22.32% 15.11%
Earnings before Tax (EBT) 1 361.2 568.6 413.3 501 535 401.5
Net income 1 256.2 415.7 291.7 344.3 393.2 266.3
Net margin 18.66% 22.57% 15.54% 15.82% 15.94% 9.57%
EPS 2 30.12 48.86 34.29 40.47 46.22 31.30
Free Cash Flow 1 -14.72 40.09 -478.6 17.08 -764.9 -507.5
FCF margin -1.07% 2.18% -25.49% 0.78% -31.02% -18.24%
FCF Conversion (EBITDA) - 5.4% - 2.37% - -
FCF Conversion (Net income) - 9.64% - 4.96% - -
Dividend per Share 2 10.00 11.00 6.600 10.00 10.00 8.000
Announcement Date 18-07-16 19-07-05 20-08-04 21-07-23 22-07-29 23-08-23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net Debt 1 557 482 1,031 884 2,030 2,593
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.126 x 0.6488 x 1.707 x 1.228 x 2.847 x 4.155 x
Free Cash Flow 1 -14.7 40.1 -479 17.1 -765 -508
ROE (net income / shareholders' equity) 17% 25% 16% 15.7% 15.7% 10.1%
ROA (Net income/ Total Assets) 10.9% 14.4% 8.63% 9.27% 7.07% 4.26%
Assets 1 2,348 2,889 3,380 3,716 5,562 6,245
Book Value Per Share 2 165.0 209.0 236.0 268.0 306.0 329.0
Cash Flow per Share 2 14.50 47.80 27.10 25.00 29.10 15.50
Capex 1 230 227 735 407 957 778
Capex / Sales 16.73% 12.3% 39.14% 18.72% 38.81% 27.95%
Announcement Date 18-07-16 19-07-05 20-08-04 21-07-23 22-07-29 23-08-23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Veterinary Drugs

1st Jan change Capi.
HESTER BIOSCIENCES LIMITED Stock Hester Biosciences Limited
+16.05% 173M
ELANCO ANIMAL HEALTH INCORPORATED Stock Elanco Animal Health Incorporated
-9.60% 6.64B
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+24.75% 3.7B
VIRBAC Stock Virbac
-2.23% 3.12B
VIMIAN GROUP AB Stock Vimian Group AB
+3.89% 1.45B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-15.13% 1.37B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-25.63% 1.24B
VETOQUINOL SA Stock Vetoquinol SA
-7.71% 1.21B
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-10.84% 1.17B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. Stock Tianjin Ringpu Bio-Technology Co.,Ltd.
-.--% 1.05B
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. HESTERBIO Stock
  4. Financials Hester Biosciences Limited